In SLE, IFN-α significantly exacerbates atherosclerosis by modulating endothelial progenitor cells (EPCs) and bone marrow-derived circulating angiogenic cells (CACs) (40). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.